• Mon news: Ventyx gets boost from Sanofi. PhRMA IRA legal challenge gets new life. AZ breast cancer drug disappoints. Teva’s once-monthly schizophrenia med. AZ gets FDA approval for first self-administered flu vaccine. See more on our front page

AbbVie preps filings after ABBV-951 tops oral Parkinson’s drugs in trial

cafead

Administrator
Staff member
  • cafead   Oct 30, 2021 at 10:52: PM
via AbbVie has reported that a subcutaneous infusion of Parkinson’s disease candidate ABBV-951 was more effective than standard oral therapy in a phase 3 trial, paving the way for regulatory filings.

article source
 

<